Sir Richard Sykes opens Argenta lab

Published: 20-Dec-2001
Sustainability


The new research laboratories of independent medicinal chemistry company Argenta Discovery were opened by Sir Richard Sykes FRS, chairman of GlaxoSmithKline plc and Rector of Imperial College of Science, Technology and Medicine.

In his welcoming speech David White, non-executive chairman of Argenta, told guests: 'We are delighted with our highly successful first year. Even though we are a very young company we have secured, and are in the process of securing, contracts with some of the biggest pharmaceutical and biotech companies in the USA and Europe.'

Led by ceo Dr Tony Baxter, Argenta Discovery integrates its experienced chemistry, biology and CADD teams to provide fast and confidential hit-to-lead and lead-to-candidate services to pharmaceutical and biotechnology companies.

See more

You may also like

Manufacturing

Signal Group launches MCERTS approved VOC emissions monitor

Read more
New SOLAR CEMNEX analyser offers advanced compliance and connectivity features

Trending Articles

  1. Suncombe and Kindeva collaborate to deliver low-carbon inhalers to the NHS The partnership will develop next-generation pressurised metered-dose inhalers with low Global Warming Potential propellants, helping the NHS move closer to its Net Zero target
  2. Ecolab and SCG sign MOU to enhance business competitiveness and drive ESG progress This 5-year MOU underscores how collaboration can turn sustainability commitments into measurable outcomes, accelerating the journey toward Net Zero while strengthening cross-industry competitiveness
  3. Gerresheimer improves Rating Result and is once again awarded EcoVadis Gold Gerresheimer, among the top 4% of all rated companies, whose rating reaches a new high with 78 out of 100 points, ranking among the top 1% of the industry underlines consistent implementation of the sustainability strategy
  4. Five API manufacturing trends you need to know in 2025 How technology, sustainability and innovation are redefining pharmaceutical production
  5. GEA raises guidance following strong H1 performance Revised forecast reflects improved margins, robust order intake and efficiency gains

Upcoming event

Enhancing probiotic stability through smarter formulation and packaging strategies

18 September 2025 | Virtual See all

You may also like

Manufacturing

Signal Group launches MCERTS approved VOC emissions monitor

New SOLAR CEMNEX analyser offers advanced compliance and connectivity features
Manufacturing

Suncombe and Kindeva collaborate to deliver low-carbon inhalers to the NHS

The partnership will develop next-generation pressurised metered-dose inhalers with low Global Warming Potential propellants, helping the NHS move closer to its Net Zero target
Sustainability

Gerresheimer improves Rating Result and is once again awarded EcoVadis Gold

Gerresheimer, among the top 4% of all rated companies, whose rating reaches a new high with 78 out of 100 points, ranking among the top 1% of the industry underlines consistent implementation of the sustainability strategy
Sustainability

Ecolab and SCG sign MOU to enhance business competitiveness and drive ESG progress

This 5-year MOU underscores how collaboration can turn sustainability commitments into measurable outcomes, accelerating the journey toward Net Zero while strengthening cross-industry competitiveness
Sustainability

Piramal Pharma publishes FY2025 sustainability report, outlining performance and decarbonization glidepath

Piramal Pharma Limited has released its fourth annual Sustainability Report for the financial year 2025, under the theme ‘Innovating Responsibly. Growing Sustainably.’
Sustainability

LOCTITE to showcase next generation of healthcare adhesive innovations

New biocompatible adhesives aim to improve safety, performance, and sustainability
Sustainability

IMCD receives upgraded ESG ratings from ISS ESG and Sustainalytics

Improvements reflect continued progress on emissions, transparency and ESG risk management
Subscribe now